In this article , there are mistakes on pages 1961, 1990 and in Tables 29 and 32 as follows:
On page 1961 right column fourth line from the top, URL link to the Systematic Coronary Risk Evaluation (SCORE) system should be, http://www.escardio.org/Guidelines-&-Education/Practice-tools/CVD-prevention-toolbox/SCORE-Risk-Charts
On page 1990, point 18.104.22.168 last paragraph line 12, ‘The ESC Guidelines for the management of myocardial infarction have recommended polypill use to improve long-term adherence to prescribed therapy (class IIa, level B) ’ should read ‘The ESC Guidelines for the management of myocardial infarction suggest that the use of the polypill may be considered to improve long-term adherence to prescribed therapy (class IIb, level B) ’.
On page 1999, Table 29 Phenotype column third line from the top, Hypokalaemia should be Hyperkalaemia.
On page 2001, Table 32 in dose column of Fenoldopam, ‘0.1 μg/kg/min i.v. infusion, increase every 15 min until goal BP is reached with 0.05 to 0.1 μg/kg/min increments’ should read, ‘0.1 μg/kg/min i.v. infusion, increase every 15 min with 0.05 to 0.1 μg/kg/min increments until goal BP is reached’.
On page 2024 left column in ESH Council section line 4 from the top, last name of a council member was incorrectly listed as Januszewics. Correct name should read, ‘Andrzej Januszewicz’
The online version has been modified.
1. Williams B, Mancia G, Spiering W, Agabiti Rosei A, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. J Hypertens